| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HRTX | Common Stock | Sale | -$2.92K | -300 | -8.57% | $9.73* | 3.2K | Dec 21, 2021 | Direct | F1, F2 |
| transaction | HRTX | Common Stock | Award | $0 | +10.5K | +326.63% | $0.00 | 13.7K | Dec 22, 2021 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HRTX | Stock Option (Right to Buy) | Award | $0 | +20.9K | $0.00 | 20.9K | Dec 22, 2021 | Common Stock | 20.9K | $9.81 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021. The shares were sold by Mr. Waage to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on December 21, 2021. |
| F2 | The range of sales prices received was $9.625 to $9.945. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. |
| F3 | The shares were granted as restricted stock units which vest in full on December 22, 2022. |
| F4 | The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. |